{"title":"《2001 - 2013年美国老年人中由丙型肝炎和乙型肝炎引起的肝细胞癌发病率》的勘误","authors":"","doi":"10.1002/cncr.34961","DOIUrl":null,"url":null,"abstract":"<p>This erratum corrects the following:</p><p>Shiels MS, Engels EA, Yanik EL, McGlynn KA, Pfeiffer RM, O’Brien TR. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013. <i>Cancer.</i> 2019;125(15):2621-2630. doi:10.1002/cncr.32129</p><p>Please note that a data importation error resulted in the age-specific hepatocellular carcinoma rates being calculated with the full population, rather than the age-specific population, as the denominator. Although this error reduced each age-specific rate, it did not change the interpretation of the trends or the inferences of the study. The authors apologize for the error and have included edited versions of Table 2 (with changes marked in italics) and Figure 2. In addition, the text on page 2625 should be edited as follows (with changes again marked in italics): “HCC rates increased across age groups (ages 66-75 years: <i>3.13%</i> per year; ages 76-85 years: <i>3.91%</i> per year; and age ≥86 years: <i>2.45%</i> per year) and were highest among individuals aged 66 to 75 years.”</p>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"129 19","pages":"3076-3078"},"PeriodicalIF":6.1000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.34961","citationCount":"0","resultStr":"{\"title\":\"Erratum to “Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013”\",\"authors\":\"\",\"doi\":\"10.1002/cncr.34961\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>This erratum corrects the following:</p><p>Shiels MS, Engels EA, Yanik EL, McGlynn KA, Pfeiffer RM, O’Brien TR. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013. <i>Cancer.</i> 2019;125(15):2621-2630. doi:10.1002/cncr.32129</p><p>Please note that a data importation error resulted in the age-specific hepatocellular carcinoma rates being calculated with the full population, rather than the age-specific population, as the denominator. Although this error reduced each age-specific rate, it did not change the interpretation of the trends or the inferences of the study. The authors apologize for the error and have included edited versions of Table 2 (with changes marked in italics) and Figure 2. In addition, the text on page 2625 should be edited as follows (with changes again marked in italics): “HCC rates increased across age groups (ages 66-75 years: <i>3.13%</i> per year; ages 76-85 years: <i>3.91%</i> per year; and age ≥86 years: <i>2.45%</i> per year) and were highest among individuals aged 66 to 75 years.”</p>\",\"PeriodicalId\":138,\"journal\":{\"name\":\"Cancer\",\"volume\":\"129 19\",\"pages\":\"3076-3078\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2023-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.34961\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cncr.34961\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cncr.34961","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
Shiels MS, Engels EA, Yanik EL, McGlynn KA, Pfeiffer RM, O 'Brien TR。2001 - 2013年美国老年人丙型肝炎和乙型肝炎的肝细胞癌发病率。癌症。2019;125(15):2621 - 2630。doi: 10.1002 / cncr。32129请注意,数据输入错误导致以全人群计算特定年龄的肝细胞癌发病率,而不是以特定年龄人群作为分母。虽然这个错误降低了每个年龄特定的比率,但它并没有改变对趋势的解释或研究的推论。作者对这个错误表示歉意,并在表2和图2中添加了编辑过的版本(有斜体标记的变化)。此外,第2625页的文本应编辑如下(再次以斜体标记的变化):“HCC发病率在各个年龄组中都有所增加(66-75岁:每年3.13%;76-85岁:每年3.91%;年龄≥86岁:每年2.45%),在66 ~ 75岁人群中最高。
Erratum to “Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013”
This erratum corrects the following:
Shiels MS, Engels EA, Yanik EL, McGlynn KA, Pfeiffer RM, O’Brien TR. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013. Cancer. 2019;125(15):2621-2630. doi:10.1002/cncr.32129
Please note that a data importation error resulted in the age-specific hepatocellular carcinoma rates being calculated with the full population, rather than the age-specific population, as the denominator. Although this error reduced each age-specific rate, it did not change the interpretation of the trends or the inferences of the study. The authors apologize for the error and have included edited versions of Table 2 (with changes marked in italics) and Figure 2. In addition, the text on page 2625 should be edited as follows (with changes again marked in italics): “HCC rates increased across age groups (ages 66-75 years: 3.13% per year; ages 76-85 years: 3.91% per year; and age ≥86 years: 2.45% per year) and were highest among individuals aged 66 to 75 years.”
期刊介绍:
The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society.
CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research